Title: Infliximab for the treatment of refractory scleritis

[1]  B. Zimmermann,et al.  Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents , 2008 .

[2]  J. Lopes,et al.  Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis. , 2008, Inflammatory bowel diseases.

[3]  S. Bickston,et al.  Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. , 2008, The Cochrane database of systematic reviews.

[4]  G. Valesini,et al.  Biological and clinical effects of anti-TNFalpha treatment. , 2007, Autoimmunity reviews.

[5]  A. Till,et al.  Current State of Biologicals in the Management of Systemic Vasculitis , 2007, Annals of the New York Academy of Sciences.

[6]  L. Sobrin,et al.  Infliximab therapy for the treatment of refractory ocular inflammatory disease. , 2007, Archives of ophthalmology.

[7]  P. Sfikakis,et al.  TUMOR NECROSIS FACTOR ANTAGONISTS: Preliminary Evidence for an Emerging Approach in the Treatment of Ocular Inflammation , 2007, Retina.

[8]  P. Mease Infliximab (Remicade) in the treatment of psoriatic arthritis , 2006, Therapeutics and clinical risk management.

[9]  C. Foster,et al.  Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use. , 2006, International ophthalmology clinics.

[10]  Justine R. Smith,et al.  A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. , 2005, Archives of ophthalmology.

[11]  H. Lamb,et al.  Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis. , 1998, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[12]  M. Raizman,et al.  Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. , 1994, American journal of ophthalmology.

[13]  C. Foster,et al.  An analysis of therapeutic decision for scleritis. , 1993, Ophthalmology.

[14]  P. G. Watson,et al.  Scleritis and episcleritis. , 1976, The British journal of ophthalmology.